Navigation Links
Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
Date:2/14/2008

ir entirety by this cautionary statement. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

--Financial Tables Follow--

SHENGTAI PHARMACEUTICAL INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31, 2007 AND JUNE 30, 2007

A S S E T S

December 31, June 30,

2007 2007

(Unaudited)

CURRENT ASSETS:

Cash $ 1,046,004 $ 6,420,439

Restricted cash 1,885,500 5,628,500

Accounts receivable, net

of allowance for doubtful

accounts of $319,887

and $431,178 as of

December 31, and June 30,

2007, respectively 6,345,988 5,779,967

Notes receivable 1,799,285 984,675

Other receivables 2,155,536 3,484,484

Other receivables -

related parties -- 2,491,656

Other receivables -

shareholder -- 1,229,625

Loan to related party -- 657,500

Inventories 4,474,855 4,449,267

Prepayments 631,130 140,376

Total current assets 18,338,298 31,266,489

PLANT AND EQUIPMENT, net 38,350,904 30,178,074
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
2. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
4. Shengtai Pharmaceutical, Inc. to Present at Roth Conference
5. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
6. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... - May 22 2013: New research shows that ... in specific regions of the brain that are ... planning actions and in motivation. Dr. Alain ... these decision-making brain regions could underlie addiction. These ... Meeting, the annual meeting of the Canadian Association ...
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Roughly four in ... obstructive pulmonary disease (COPD) actually do not have the ... issue: Faulty diagnoses were made based on an evaluation ... "gold standard" disease test known as spirometry, which shows ... the amount of air they can exhale and how ...
(Date:5/22/2013)... the University of Melbourne said this small increase in ... from CT scans in diagnosing and monitoring disease. , ... Medical Journal today and involved researchers at eight ... Agency for Research on Cancer in Lyon, France. ... in providing detailed three dimensional pictures to diagnose or ...
(Date:5/22/2013)... Prussia, PA (PRWEB) May 22, 2013 The ... to announce its participation in the Greater Philadelphia Tour de ... and recreational riders who are passionate about stopping the ... than 25 million Americans. , The Tour de Cure ... located at 580 Meetinghouse Road in Ambler, 30 minutes outside ...
(Date:5/22/2013)... 22, 2013 CoCENTRIX, a leading ... Health and Human Services and community providers, announced ... (ADMH) selected the CoCENTRIX Coordinated Care Platform ... the Health Records and coordinate care within and ... , CoCENTRIX is transitioning the hospitals' official records ...
Breaking Medicine News(10 mins):Health News:Addiction as a disorder of decision-making 2Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 3
... that are a biological blank slate, have the potential to ... wide variety of organs and tissues. Their potential to treat ... of the ongoing ethical debate over harvesting hESCs, a process ... in the U.S. because it involves federal funding for research. ...
... to treat a variety of tumors and the response ... death, which in turn limits oxygen delivery ... Recently, radiation-induced hypoxia was shown to trigger tumor resistance ... formation (angiogenesis) through molecules known as HIF-1regulated cytokines. In ...
... community hospita,l in Detroit with 285 beds, specializing in general ... failure, diabetes and obstetrics. ,Detroit is the largest ... a prosperous region. ,But Riverview is all ... week said it was losing too much money and already ...
... high court proved that collective bargaining rights are indeed protected ... against the provincial government which was supporting the Bill 29 ... union contracts, has been hailed by union and labor leaders ... provide labor flexibility, by the then B.C Liberal government, ...
... endangers human lives and generates billions of dollars every year ... ,Unlike drug smuggling, however, medicine counterfeiting is still not considered ... of east European countries including Ukraine. ,"We tell ... drop them. ,It's not a crime," said an ...
... The Chinese Food and Drug administration has put a halt ... for irritable bowel syndrome, as the risk associated with ... taking the medication. ,The Chinese Drug watchdog posted ... the possible benefits for some patients based on analyses from ...
Cached Medicine News:Health News:Dartmouth Professor Makes Case for Ethically Universal Stem Cell Lines 2Health News:Hospitals in Older Cities Close Down, Blacks Worst Affected 2Health News:Hospitals in Older Cities Close Down, Blacks Worst Affected 3Health News:Fangs Taken Out of Canadas Bill 29 2Health News:Ukraine Struggles Against Fake Drug Trade 2Health News:Ukraine Struggles Against Fake Drug Trade 3
(Date:5/22/2013)... LEWIS CENTER, Ohio , May 22, 2013 ... of Opioid Defense Manager™ (ODM).  Launched in November ... Medical,s revolutionary managed care program to stop the ... ODM is a proactive, customized program designed to ... drug use while maintaining the necessary balance to ...
(Date:5/22/2013)... -- Z-Medica, a leading developer and marketer of hemostatic ... of products designed to meet the unique needs of ... EMS 4x4 Dressing, QuikClot ® EMS TraumaPad ® ... custom-designed to help responders stop bleeding fast and keep ... hospital or trauma center. The line includes products designed ...
(Date:5/22/2013)... MAPLE GROVE, Minn. , May 22, ... today announced the successful completion of its ... (extended-release topiramate), an internally developed program for ... the company,s proprietary formulation technology.  USL255 is ... and reduce fluctuations in topiramate blood levels ...
Breaking Medicine Technology:Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4
... SAN DIEGO, Feb. 18, 2011 Zimmer Holdings, Inc. (NYSE: ... care, today announced it has received FDA clearance for the ... TM-S system is the industry,s first cervical interbody device incorporating ... device for cervical interbody fusion (IBF) in the United ...
... Bellicum Pharmaceuticals, Inc. today announced the presentation ... BPX-101, a novel drug-activated dendritic cell vaccine for ... separate posters at the 2011 Genitourinary Cancers Symposium ... 19, 2011. Three leading medical specialty societies co-sponsor ...
Cached Medicine Technology:Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 2Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 3Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine 2Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine 3
... the hand, the Jarvik 2000 pump is about ... welded titanium shell sits a direct-current motor, a ... single moving part: a small, spinning titanium impeller ... to 7 liters per minute. Rather than take ...
... cardiac assist system primarily designed as a permanent ... failure., ,It is a blood pump that connects ... to help the ailing hearts pumping function and ... , ,It can also be used as a ...
... The Masimo SET LNOP Blue Sensor is ... babies. The LNOP Blue sensor is ... accuracy claims for cyanotic infants and children. ... presented challenging conditions for reliable and accurate ...
... The Trinity Biotech Captia™ Varicella-Zoster Virus (VZV) ... for the detection and quantitative determination of ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
Medicine Products: